Last 12 months
Inside the activity.
14 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 8 | 0 |
| Jul 2026 | 6 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 11, 2026 20:53 UTC |
Borisy AlexisDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,215 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001193125-26-267806 · ownership.xml · derivative · entry 1 Borisy Alexis · CIK 0001319446 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,215 Underlying: Common Stock · 20,215 shares Expires 2036-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 22:36 UTC |
RA CAPITAL MANAGEMENT, L.P.Director
RA Capital Healthcare Fund LPDirector
RA Capital Nexus Fund III, L.P.Director
Kolchinsky PeterDirector
Shah Rajeev M.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,215 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000623 · form4-06112026_100601.xml · derivative · entry 1 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director RA Capital Healthcare Fund LP · CIK 0001315082 · Director RA Capital Nexus Fund III, L.P. · CIK 0001883840 · Director Kolchinsky Peter · CIK 0001384859 · Director Shah Rajeev M. · CIK 0001619841 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 20,215 Underlying: Common Stock · 20,215 shares Expires 2036-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to Dr. Simson's continued service on such vesting date. F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. F3 · ownership.nature: Under Dr. Simson's arrangement with the Adviser, Dr. Simson holds the option for the benefit of the Fund and the Nexus Fund III. Dr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund III to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:52 UTC |
Yeshwant KrishnaDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,215 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001193125-26-267797 · ownership.xml · derivative · entry 1 Yeshwant Krishna · CIK 0001585001 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,215 Underlying: Common Stock · 20,215 shares Expires 2036-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:48 UTC |
FITZGERALD EDWARD MDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,215 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001193125-26-267769 · ownership.xml · derivative · entry 1 FITZGERALD EDWARD M · CIK 0001242993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,215 Underlying: Common Stock · 20,215 shares Expires 2036-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:43 UTC |
Klausner RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,215 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001193125-26-267747 · ownership.xml · derivative · entry 1 Klausner Richard · CIK 0001591178 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,215 Underlying: Common Stock · 20,215 shares Expires 2036-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.